Fig. 3
Targeting PI3K/AKT/mTOR pathway by CRISPR/Cas9 in prostate cancer. Modification of expression of these targets has led to reduction of prostate cancer cell proliferation. Figure was depicted using BioRender
Fig. 3 | Cell Communication and Signaling